Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Filings indexed 1,398 across all filing types
Latest filing 2015-07-13 Report Publication Anno…
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Report Publication Announcement 2015
Report Publication Announcement Classification · 100% confidence The document is very short (1541 characters) and explicitly states that it is an 'Announcement according to articles 37v, 37w, 37x ff. WpHG' regarding the 'disclosure of financial statements'. It specifies the report type ('Financial report of the group (half-year/Q2)') and provides the future 'Date of disclosure' (August 06, 2015), but it is not the report itself. This fits the definition of announcing the publication of a report. Since it announces the release of a financial report, the most specific category is Report Publication Announcement (RPA).
2015-07-13 English
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states it is a 'Total Voting Rights Announcement' according to Article 26a of the WpHG (German Securities Trading Act). It reports the total number of voting rights as of June 30, 2015. This type of announcement, which details the total number of shares carrying voting rights, is a specific regulatory disclosure. Among the provided codes, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most appropriate fit for reporting the total voting rights count, as it relates directly to shareholder voting power.
2015-06-30 English
Roadshow Benelux: (Präsentation)
Investor Presentation Classification · 98% confidence The document is titled 'Roadshow Benelux June 29/30, 2015' and contains detailed slides presenting the company's portfolio, segment performance (Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed), financial results for Q1/15, updated outlooks, and historical performance comparisons. This structure—a presentation format with segment breakdowns, financial tables, and forward-looking guidance updates—is characteristic of an Investor Presentation (IP). It is not a full Annual Report (10-K), a short Earnings Release (ER), or a transcript (CT). Since it is a comprehensive presentation intended for investors during a roadshow, 'Investor Presentation' (IP) is the most appropriate classification.
2015-06-29 English
J. P. Morgan - European Healthcare Conference 2015: (Präsentation)
Investor Presentation Classification · 98% confidence The document is titled 'J.P. Morgan - European Healthcare Conference 2015' and is dated June 25, 2015. It contains detailed slides covering the performance of various business segments (Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed) for 2014 and Q1/15, including sales, EBIT, growth rates, and updated financial guidance. This structure—a presentation delivered at a specific conference, summarizing recent financial results and outlook—is characteristic of an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K or IR, nor is it a short announcement of a report (RPA/RNS).
2015-06-25 English
Deutsche Bank - dbAccess German, Swiss & Austrian Conference: (Präsentation)
Investor Presentation Classification · 98% confidence The document text is a presentation slide deck, indicated by the structure (headings, bullet points, tables summarizing data, and explicit mention of a conference: "Deutsche Bank ‒ dbAccess German, Swiss & Austrian Conference June 18, 2015"). It contains detailed financial results for Q1/15, segment performance updates, and revised outlooks. This content strongly aligns with an Investor Presentation (IP), which typically includes financial highlights and strategic updates presented to investors at conferences or roadshows. It is not a full regulatory report (like 10-K or IR), nor is it merely an announcement of a report (RPA). The presence of a Safe Harbor statement and the format confirm it is an investor-facing presentation material.
2015-06-18 English
Citi - European Healthcare Conference 2015: (Präsentation)
Investor Presentation Classification · 98% confidence The document is titled as a presentation given at the 'Citi - European Healthcare Conference 2015' on June 16, 2015. It contains detailed segment performance data (Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed), financial highlights for Q1/15, updated guidance, and concluding with a 'Fresenius Group: Profit and Loss Statement' table. This structure—a presentation format summarizing recent performance, strategy updates, and outlook—is characteristic of an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K or IR, nor is it a brief announcement (RPA/RNS) as the document is substantial and detailed.
2015-06-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.